TP53 and lung adenocarcinoma: Increased NFκB activity has been found in p53-null mice and p53 loss was reported to promote activation of NFκB in a mouse model of KrasG12D-driven lung adenocarcinoma, while restoring p53 in p53-null lung tumors blocked NFκB activation and led to tumor suppression [89,90].